๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-12-18

Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening (NCT07052266)

Feasibility of Obstetric and Cancer Universal Screening

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿ“‹ Clinical Research Protocol Sponsor: Weill Medical College of Cornell University

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care. The goal is to evaluate the acceptability of BRCA1/2 testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention and be cost-effective, especially among underserved populations.

Who can join: Review the eligibility criteria below.

Location: Reproductive Medicine โ€” Brooklyn, New York

Age range: 18 Years to 55 Years

๐Ÿงช Interventions in This Study

  • MyRisk Hereditary Cancer Test (GENETIC)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (5 Sites)

  • Reproductive Medicine โ€” Brooklyn, New York
  • NewYork-Presbyterian Weill Cornell Medicine โ€” Brooklyn, New York
  • Reproductive Medicine โ€” New York, New York
  • Weill Cornell Medicine โ€” New York, New York
  • NewYork-Presbyterian Weill Cornell Medicine Queens โ€” Queens, New York

๐Ÿ“ž Contact the Study Coordinator

Phone: (914) 312-7488

Email: stl4013@med.cornell.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Hereditary Cancer Syndromes

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—